CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development

Scott Demarest(Colorado School of Public Health), Heather E. Olson(Boston Children's Hospital), Angela Moss(Outcomes Research Consortium), Elia Pestana‐Knight(Cleveland Clinic), Xiaoming Zhang(Cleveland Clinic), Sumit Parikh(Cleveland Clinic Lerner College of Medicine), Lindsay C. Swanson(Boston Children's Hospital), Katherine D. Riley(Boston Children's Hospital), Grace A. Bazin(Boston Children's Hospital), Katie Angione(Children's Hospital Colorado), Lisa‐Marie Niestroj(University of Cologne), Dennis Lal(Broad Institute), Elizabeth Juarez‐Colunga(Colorado School of Public Health), Tim A. Benke(Colorado School of Public Health)
Epilepsia
July 16, 2019
Cited by 162Open Access
Full Text

Abstract

OBJECTIVE: The cyclin-dependent kinase like 5 (CDKL5) gene is a known cause of early onset developmental and epileptic encephalopathy, also known as CDKL5 deficiency disorder (CDD). We sought to (1) provide a description of seizure types in patients with CDD, (2) provide an assessment of the frequency of seizure-free periods and cortical visual impairment (CVI), (3) correlate these features with genotype and gender, and (4) correlate these features with developmental milestones. METHODS: This is a cohort study of patients with CDD. Phenotypic features were explored and correlated with gene variant grouping and gender. A developmental score was created based on achieving seven primary milestones. Phenotypic variables were correlated with the developmental score to explore markers of better developmental outcomes. Multivariate linear regression was used to account for age at last visit. RESULTS: Ninety-two patients with CDD were seen during the enrollment period. Eighteen were male (19%); median age at last visit was 5 years (interquartile range = 2.0-11.0). Eighty-one percent of patients developed epileptic spasms, but only 47% of those also had hypsarrhythmia. Previously described hypermotor-tonic-spasms sequence was seen in only 24% of patients, but 56% of patients had seizures with multiple phases (often tonic and spasms). Forty-three percent of patients experienced a seizure-free period ranging from 1 to >12 months, but only 6% were still seizure-free at the last visit. CVI was present in 75% of all CDD patients. None of these features was associated with genotype group or gender. CVI was correlated with reduced milestone achievement after adjusting for age at last visit and a history of hypsarrhythmia. SIGNIFICANCE: The most common seizure types in CDD are epileptic spasms (often without hypsarrhythmia) and tonic seizures that may cluster together. CVI is a common feature in CDD and is correlated with achieving fewer milestones.


Related Papers

No related papers found

Powered by citation graph analysis